retatrutide phase 2 trial Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% weight loss in half of people with #obesity. This amount of weight loss has not been accomplished Retatrutide Phase 2 vs Phase

Research is also evaluating it beyond weight loss, including osteoarthritis and chronic pain, with ongoing studies looking at knee osteoarthritis pain and chronic low back pain rather than proven benefit

Use a permanent marker to write the opened date and discard after date directly on the vial label

A combination of resistance training at least two to three times per week and protein intake of 1.2 to 1.6 g/kg per day has been shown to preserve and even increase lean mass during caloric restriction

Does FSA or HSA money work for Ozempic

While oral peptide delivery is a major area of research for other compounds, published data on an oral Retatrutide is not yet available